ArticleAnalytical and bioanalytical chemistry2026
Evaluating the chemical safety of bio-based and biodegradable food packaging materials through non-targeted LC-HRMS analysis and in vitro bioassays.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Bio-based and/or biodegradable polymers like all food-contact materials shall not transfer their constituents to food in quantities which could endanger human health. This work aims to evaluate the chemical safety of food contact bioplastics through an approach that combines a non-targeted liquid chromatography-high-resolution mass spectrometry (LC-HRMS) analysis emphasizing low-molecular weight oligomers and in vitro bioassays, including cytotoxicity assay, ROS production, inflammation tests, and in vitro assays to assess the endocrine activity. Seventeen samples including bio-polypropylene, bio-polyethylene, bio-polyester-based materials, bio-polyester-polyvinyl alcohol (PVOH), and polylactic acid (PLA)-based materials were assessed. A variety of different families of oligomers, specifically oligoesters, caprolactone oligomers, cyclic and linear oligomers of lactic acid (LA), and methoxylated and ethoxylated LA linear oligomers, were identified. Additives as well as their degradation products were also detected. An extract from each type of material was subjected to in vitro bioassays as part of hazard identification. The results showed that PLA, bio-polyester, and bio-polyester-PVOH showed the highest cytotoxicity, and bio-polypropylene and bio-polyethylene exhibited endocrine-disrupting potential. Furthermore, extracts from PLA have been shown to induce inflammation through high ROS production.
Indexed as
Identifiers
41398089What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.